Search
forResearch 10 of 1000+
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- New developments in our understanding of acne pathogenesis and treatment
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
Community 6 of 39
- Insulins impact on androgen levels
- Does high sugar/insulin resistance or generally bad diet prevent fin/dut from working?
- Claim: Insulin resistance increases the enzyme that creates DHT and affects the liver's ability to control hormones
- Anyone with high glucose, insulin resistance, pre-diabetes or diabetes notice any regrowth after starting treatment?
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- 22M Seeking Advice: Gyno, Insulin Resistance and Hair Loss Solutions